Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)

NCT01295294 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Hemorrhage

Interventions

DRUG: Tranexamic acid
DRUG: Mefenamic acid
DRUG: Placebo
DRUG: Mirena (Levonorgestrel IUS, BAY86-5028)

Sponsor

Bayer